Oropouche Virus Threat to Texas Stalls in Southern Mexico

Mexican health authorities have confirmed the country's first cluster of locally transmitted Oropouche virus cases in southern states, raising concerns about the virus's spread northward and its implications for regions near the U.S. border.

The Secretariat of Health reported a small number of confirmed infections in Chiapas and Tabasco, identified through enhanced arbovirus surveillance and verified by RT-PCR testing. These cases involve residents with no recent travel history outside the country, indicating local transmission by biting midges and possibly mosquitoes.

Chiapas is located in southeastern Mexico along the border with Guatemala, while Tabasco is situated farther north, still within the tropical lowlands of the Gulf of Mexico region. These states are approximately 1,200 miles south of Texas.

Mexican health officials attribute this emergence to increased regional viral circulation, favorable warm and humid conditions for the vectors, and heightened human mobility.

Further south, Brazil continues to bear the heaviest burden of the Oropouche virus in the Americas. Although complete nationwide figures for the early months of 2026 are still being compiled, surveillance data indicate approximately 12,000 cases across all 27 federal units.

In the Caribbean, Cuba, which saw a significant surge in 2025 with over 4,100 locally acquired cases reported by November, has experienced continued but lower-level transmission into 2026. Earlier data for 2026 showed 4,100 suspected cases.

To date, all reported cases of the Oropouche virus in the U.S. remain travel-associated, with no evidence of local transmission. U.S. health authorities, including the Texas Department of State Health Services, currently assess the risk of sustained local transmission in Texas and other continental U.S. states as low.

However, experts caution that this risk could increase in 2026 under certain conditions.

Travelers to southern Mexico, including Chiapas and Tabasco, or other affected areas, should follow the U.S. CDC's Level 1 travel health advice and take usual precautions. Residents of Texas and other border states planning cross-border travel are encouraged to monitor updates from the CDC and Texas DSHS.

As of April 14, 2026, the CDC does not recommend any vaccine targeting the Oropouche virus for individuals.